Annual Total Liabilities
$569.55 M
+$72.97 M+14.69%
December 31, 2023
Summary
- As of February 10, 2025, CERE annual total liabilities is $569.55 million, with the most recent change of +$72.97 million (+14.69%) on December 31, 2023.
- During the last 3 years, CERE annual total liabilities has risen by +$508.80 million (+837.49%).
Performance
CERE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$562.89 M
-$6.67 M-1.17%
March 31, 2024
Summary
- As of February 10, 2025, CERE quarterly total liabilities is $562.89 million, with the most recent change of -$6.67 million (-1.17%) on March 31, 2024.
- Over the past year, CERE quarterly total liabilities has increased by +$13.89 million (+2.53%).
Performance
CERE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CERE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.7% | +2.5% |
| 3 y3 years | +837.5% | +480.0% |
| 5 y5 years | +1225.1% | +480.0% |
CERE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -80.7% | -1.2% | -82.8% |
| 5 y | 5-year | at high | -92.5% | -1.2% | -98.6% |
| alltime | all time | at high | -92.5% | -1.2% | -98.6% |
Cerevel Therapeutics Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $562.89 M(-1.2%) |
| Dec 2023 | $569.55 M(+14.7%) | $569.55 M(+3.7%) |
| Sep 2023 | - | $549.00 M(+0.9%) |
| Jun 2023 | - | $543.85 M(+9.1%) |
| Mar 2023 | - | $498.64 M(+0.4%) |
| Dec 2022 | $496.58 M | $496.58 M(+1.3%) |
| Sep 2022 | - | $490.35 M(+240.9%) |
| Jun 2022 | - | $143.84 M(+48.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $97.05 M(-11.9%) |
| Dec 2021 | $110.19 M(+81.4%) | $110.19 M(+5.5%) |
| Sep 2021 | - | $104.40 M(+7.5%) |
| Jun 2021 | - | $97.12 M(+42.7%) |
| Mar 2021 | - | $68.07 M(+12.0%) |
| Dec 2020 | $60.75 M(+41.3%) | $60.75 M(+666.2%) |
| Sep 2020 | - | $7.93 M |
| Dec 2019 | $42.98 M | - |
FAQ
- What is Cerevel Therapeutics Holdings annual total liabilities?
- What is the all time high annual total liabilities for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual total liabilities year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly total liabilities year-on-year change?
What is Cerevel Therapeutics Holdings annual total liabilities?
The current annual total liabilities of CERE is $569.55 M
What is the all time high annual total liabilities for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual total liabilities is $569.55 M
What is Cerevel Therapeutics Holdings annual total liabilities year-on-year change?
Over the past year, CERE annual total liabilities has changed by +$72.97 M (+14.69%)
What is Cerevel Therapeutics Holdings quarterly total liabilities?
The current quarterly total liabilities of CERE is $562.89 M
What is the all time high quarterly total liabilities for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly total liabilities is $569.55 M
What is Cerevel Therapeutics Holdings quarterly total liabilities year-on-year change?
Over the past year, CERE quarterly total liabilities has changed by +$13.89 M (+2.53%)